Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 73,"Stieber D, et al., Int J Cancer. 2007 Jan 17",mammary gland integrity trait,,RS:0001450,SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm,female,191 days to 186 days,46,,CMO:0000343,mammary tumor number,,,,7.61,,0.0663,0.45,MMO:0000344,necropsy,,0,necropsy,DMBA oral gavage,,,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ",11342,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) " 74,"Piessevaux G, et al., Mamm Genome. 2008 Dec 4",mammary gland integrity trait,,RS:0001450,SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm,female,0 days,46,,CMO:0000343,mammary tumor number,,,,7.61,,0.45,3.052,MMO:0000158,manual palpation method,,0,,DMBA oral gavage,133,days,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days)",11356,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days)" 73,"Stieber D, et al., Int J Cancer. 2007 Jan 17",mammary gland integrity trait,,RS:0001450,SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm,female,120 days to 99 days,46,,CMO:0000344,mammary tumor growth rate,,the first 3 weeks of tumor growth,,0.79,cm/week,0.0074,0.05,MMO:0000160,unspecified method,,0.0,,DMBA oral gavage,,,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ",11348,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) " 74,"Piessevaux G, et al., Mamm Genome. 2008 Dec 4",mammary gland integrity trait,,RS:0001450,SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm,female,0 days,52,,CMO:0000344,mammary tumor growth rate,,the first 3 weeks of tumor growth,,0.73,cm/week,0.03,0.2163,MMO:0000160,unspecified method,,0,,DMBA oral gavage,,,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days)",11511,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days)" 73,"Stieber D, et al., Int J Cancer. 2007 Jan 17",mammary gland integrity trait,,RS:0001450,SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm,female,104 days to 99 days,46,,CMO:0000345,post-insult time to mammary tumor formation,,,,45.91,d,0.1873,1.27,MMO:0000158,manual palpation method,,0,,DMBA oral gavage,,,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ",11345,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) " 709,"Lella V, et al., Int J Cancer. 2007 Oct 15;121(8):1738-43.",mammary gland development trait,,RS:0001450,SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm,female,55 days,5,,CMO:0001084,mammary gland terminal end bud count,,,,60.3,,4.9,10.9567,MMO:0000111,ex vivo light microscopy,,0,,,,,control condition,66137,control condition